NLS-2 (Mazindol Extended Release)

mazindol extended release · NLS Pharmaceutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NLS-2 (Mazindol Extended Release), covering 2022-08-12 to 2024-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 [Phase 3]